Comparison of Oxidants and Antioxidants in Breastmilk Under Different Anesthesia Protocols
Launched by DUZCE UNIVERSITY · Feb 5, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of anesthesia (general and regional) used during cesarean sections affect the levels of oxidants and antioxidants in breastmilk. Oxidants are substances that can cause stress in the body, while antioxidants help protect against that stress. By comparing the breastmilk of women who had general anesthesia with those who had regional anesthesia, researchers hope to understand if the type of anesthesia makes a difference in the breastmilk's quality shortly after surgery.
To be eligible for this study, women must be undergoing a cesarean section and fall into specific health categories (not too high-risk) according to the American Society of Anesthesiologists. If you participate, you'll be asked to provide a small sample (just 2 ml) of your breastmilk about six hours after your surgery. This study is currently recruiting participants, so if you meet the eligibility criteria, it could be a valuable opportunity to contribute to important research that may help new mothers and their babies in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing cesarean section under general or regional anesthesia
- • Patients in the I and II risk groups, according to the American Society of Anesthesiologists (ASA) classification
- Exclusion Criteria:
- • Pregnant women with ASA III and above,
- • Pregnant women with gestational DM or hypertension,
- • Pregnant women with an indication for Intensive Care Unit (ICU),
- • Pregnant women with chronic obstructive pulmonary disease,
- • Pregnant women with morbid obesity,
- • Pregnant women with a history of liver or kidney disease,
- • Pregnant women with coronary artery disease or heart failure,
- • Pregnant women with significant anemia (Hg\<7).
About Duzce University
Düzce University is a prominent academic institution located in Turkey, dedicated to advancing medical research and innovation. As a clinical trial sponsor, Düzce University leverages its extensive expertise in various fields of health sciences to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing therapeutic strategies. The university fosters collaboration among multidisciplinary teams and prioritizes ethical standards and regulatory compliance in its research endeavors. Through its commitment to scientific excellence and community health, Düzce University plays a pivotal role in contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Duzce, , Turkey
Patients applied
Trial Officials
Özlem Ersoy Karka, Ass. Prof.
Principal Investigator
Düzce University Faculty of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported